No Picture
Los Angeles Biotech News

City of Hope and CytoImmune announce study demonstrating novel off-the-shelf chimeric antigen receptor (CAR) natural killer (NK) cell-based therapy against pancreatic cancer

DUARTE, Calif. & TOA BAJA, Puerto Rico–(BUSINESS WIRE)–City of Hope, a world-renowned cancer research and treatment organization, and CytoImmune Therapeutics, a clinical-stage immunotherapy company that is developing a novel class of natural kill… […]

No Picture
Los Angeles Biotech News

BGG World Announces Appointment of Shaheen Majeed to CEO Position of BGG Americas & Subsidiaries

IRVINE, Calif.: IRVINE, Calif., Jan. 18, 2022 /PRNewswire/ — BGG World (BGG) is extremely pleased to announce the appointment of industry veteran Shaheen Majeed to the position of CEO of three of its key subsidiaries. Mr. Majeed assumed the role of CE… […]

No Picture
Los Angeles Biotech News

CytRx to Hold Town Hall for Stockholders on Thursday, January 20th

LOS ANGELES–(BUSINESS WIRE)–CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today announced that it wil… […]

No Picture
Los Angeles Biotech News

Dermavant Presents New Patient Satisfaction Data from PSOARING 3 Long Term Extension Trial of Tapinarof in Adults with Plaque Psoriasis at the 2022 Winter Clinical Dermatology Conference

LONG BEACH, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Dermavant Presents New Patient Satisfaction Data from PSOARING 3 Long Term Extension Trial of Tapinarof in Plaque Psoriasis at 2022 Winter Clinical […]

No Picture
Los Angeles Biotech News

#JPM22: Highlights for the year ahead in oncology R&D — What’s hot, what’s not?

Across the broad spectrum of oncology drug development, 2021 marked a year of breakthroughs with off-the-shelf cell therapies coming into their own (with some questions) as classically “undruggable” targets fell to the inevitable march of progress. In … […]

No Picture
Los Angeles Biotech News

Eric Ostertag reaching the end of the line as Poseida chief, will become executive chairman; Alector exec named CEO of Pfizer-backed LNP biotech

Eric Ostertag → The Poseida adventure takes another turn as CEO Eric Ostertag dives into the role of executive chairman and CBO Mark Gergen steers the ship starting Feb. 1. Ostertag talked through Poseida’s early proof-of-concept data with its PSMA-tar… […]

No Picture
Los Angeles Biotech News

Largest Catalent site will expand cold chain offerings; First phase completed for Avid’s CA upgrade 

A Philadelphia Catalent site will get an increase in cold-chain packaging capabilities to gear up for any future increases in gene and cell therapies. The site will be expanded by 20,000 square feet and add an additional seven temperature-controlled pr… […]